Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.40 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28239756 | 0.82 | TP53 (0.40) | TP53SLC7A5MAPT | |
| SCHEMBL1033384 | 0.77 | — | — | |
| SCHEMBL135699 | 0.77 | — | — | |
| SCHEMBL583938 | 0.77 | — | — | |
| SCHEMBL1442241 | 0.77 | — | — | |
| SCHEMBL30730719 | 0.77 | — | — | |
| SCHEMBL7110381 | 0.77 | TP53 (0.40) | TP53SLC7A5MAPT | |
| SCHEMBL1059263 | 0.75 | LMNA (0.32) | TP53MAPT | |
| Hydrochloric Acid SCHEMBL9505353 | 0.74 | — | — | |
| SCHEMBL6908472 | 0.74 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107876092-B | Application of titanium catalyst with cyclic structure as reaction catalyst for synthesizing benzyl carbonate or diphenyl carbonate by ester exchange | 华东理工大学 | 2023-01-10 | — | — | CN | claimed |
| CN-101801906-A | Process for preparing 4-fluoro substituted 3-oxo-alkanoic acid esters | SOLVAY | 2010-08-11 | — | — | CN | disclosed |
| EP-1362842-B1 | PROCESS FOR PRODUCING 2-FLUORO-3-OXOALKYLCARBOXYLIC ACID ESTER | TOSOH F TECH INC (JP) | 2007-03-14 | — | — | EP | disclosed |
| US-7019162-B2 | Vapor phase fluorination of an oxocarboxylic ester | TOSOH F-TECH, INC. (JP) | 2006-03-28 | — | — | US | disclosed |
| US-20040054217-A1 | Process for preparing 2-fluoro-3-oxoalkylcarboxylic acid ester | TOSOH F-TECH, INC. (JP) | 2004-03-18 | — | — | US | disclosed |
| EP-1362842-A1 | PROCESS FOR PRODUCING 2-FLUORO-3-OXOALKYLCARBOXYLIC ACID ESTER | Tosoh F-Tech, Inc. (JP) | 2003-11-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040054217-A1 | Process for preparing 2-fluoro-3-oxoalkylcarboxylic acid ester | PFAS, ALKBH3, FTO | TP53 2803/4885SLC7A5 1394/4885MAPT 4378/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.